Diastolic Dysfunction in Aortic Regurgitation

Status Completed

Clinical Trial Summary

Follow-up study in patients with severe aortic regurgitation after successful valve replacement. Systolic and diastolic function were assessed and persistent diastolic dysfunction was observed late (7-10 years) after operation.

Clinical Trial Description

Background

Patients with severe aortic regurgitation show eccentric LV hypertrophy and structural changes of the myocardium. Reversibility of functional and structural changes after successful valve replacement may be limited. Persistent diastolic dysfunction has been observed in the present study late after aortic valve replacement. This finding has been explained by incomplete regression of the extra-cellular matrix 7 years after valve replacement. Interstitial fibrosis remains unchanged compared to the preoperative situation but was increased early after operation due to the reduction in LV muscle mass. Regression of LV hypertrophy was 40% after 2 and 55% after 7 years of valve replacement. Myocardial muscle fibers decreased slightly but remained hypertrophied even late after operation. Interstitital fibrosis was found to be positively correlated to myocardial stiffness and inversely to LV ejection fraction.

Thus, persistent diastolic dysfunction with maintained systolic ejection performance can be observed late after successful valve replacement in patients with severe aortic regurgitation. Altered diastolic function has been associated with increased filling pressures during strenuous exercise with signs of dyspnea.

Objective

Evaluation of myocardial structure and function in patients with chronic volume overload before and after valve replacement(LV-remodeling).

Methods

Pressure-volume measurements and myocardial biopsy samples for assessing myocardial function and structure. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00976625
Study type	Interventional
Source	University of Bern
Contact
Status	Completed
Phase	N/A
Start date	January 1996
Completion date	December 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03314857` - China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population	N/A
Completed	`NCT03666351` - Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease	Phase 4
Recruiting	`NCT06034028` - J-Valve TF Early Feasibility Study	N/A
Completed	`NCT05515848` - Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David
Active, not recruiting	`NCT03549091` - Accuracy of Left Subclavian Regurgitation Evaluated by Ultrasound Doppler and 4D Flow MRI	N/A
Completed	`NCT01598844` - JUPITER Study: Transapical Aortic Valve Implantation for Aortic Regurgitation
Active, not recruiting	`NCT03466918` - China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population	N/A
Active, not recruiting	`NCT04415047` - The JenaValve ALIGN-AR Pivotal Trial	N/A
Not yet recruiting	`NCT05319171` - Performance of Currently Available traNscaTHEter Aortic Valve Platforms in Inoperable Patients With Pure Aortic regurgitatiON of a Native Valve. The PANTHEON International Project.
Completed	`NCT05774795` - LOng-Term Fate of Moderate Aortic Regurgitation Left Untreated at the Time of Mitral Valve Surgery
Terminated	`NCT02351726` - Mitroflow DL Post Approval Study- North America	N/A
Completed	`NCT00624884` - Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation	N/A
Withdrawn	`NCT05409378` - HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation	N/A
Recruiting	`NCT04038879` - Comparison Study of Echocardiography and Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral and Aortic Regurgitation
Completed	`NCT05332184` - Cardiac T1 Mapping Enables Risk Prediction of LV Dysfunction After Surgery for Aortic Regurgitation
Completed	`NCT01400841` - HAART Model 300 Annuloplasty Ring	N/A
Not yet recruiting	`NCT02633423` - Expiratory Flow Limitation and Mechanical Ventilation During Cardiopulmonary Bypass in Cardiac Surgery	N/A
Enrolling by invitation	`NCT05714293` - CT-evaluation of Coronary Ostia Height After Surgical Aortic Valve Replacement.	N/A
Recruiting	`NCT02974920` - Rivaroxaban or Aspirin for Biological Aortic Prosthesis	Phase 4
Not yet recruiting	`NCT03788590` - Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System	N/A